DrugDashboards

Bexagliflozin

Bexagliflozin · BEXAGLIFLOZIN 20 mg/1 · Tablet · Oral · Golden State Medical Supply, Inc.

NDC 51407-0918-30 · 30 TABLET in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA214373
TE code
Approval date
Jan 20, 2023
Patents / exclusivity
7 patents, 1 exclusivities
TypeNumber / codeExpires
exclusivityNCEJan 20, 2028
patent12594243Oct 5, 2041
patent8987323May 14, 2032
patent10533032Jul 3, 2031
patent10981942Jun 13, 2031
patent7838499Jan 30, 2029
patent8106021Aug 22, 2028
patent8802637Aug 22, 2028

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bexagliflozin (Tablet)

LabelerStrengthFirst seenLast seen
Golden State Medical Supply, Inc.BEXAGLIFLOZIN 20 mg/1Jul 15, 2026Sep 2, 2026
TheracosBio, LLCBEXAGLIFLOZIN 20 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Bexagliflozin — NDC 51407-0918-30," retrieved September 3, 2026, https://drugdashboards.com/drug/51407091830.

Free to cite with attribution — see how the data is put together.